Paronychia
📧 Sign up to get email alerts when something new happens for Paronychia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors [Phase 2]
Phase 2 clinical trial evaluating topical HT-001 for treating EGFR inhibitor–related skin toxicities (acneiform eruption, xerosis cutis, and…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Safety and Efficacy of Intralesional 0.5% Triamcinolone Acetonide in 0.2% Fluconazole Solution vs 0.1% Topical Mometasone Furoate With 2% Miconazole Nitrate Cream in the Treatment of Chronic Paronychia: An Intraindividual Randomized Controlled Trial. [Phase 3]
This clinical trial update reports a Phase 3 intraindividual randomized study evaluating two treatment regimens for chronic paronychia: intr…
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Efficacy and Safety of Add-on Timolol for EGFR-TKI and ALK-TKI Induced Paronychia [Phase 3]
A Phase 3 trial is evaluating add-on timolol for paronychia induced by EGFR-TKI and ALK-TKI therapies; the study is currently recruiting.